PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
作者信息
Flaherty J M
出版信息
Food Drug Law J. 2001;56(3):339-49.
PMID:11944643
Abstract
摘要
相似文献
1
PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
Food Drug Law J. 2001;56(3):339-49.
2
The use of Food and Drug Administration 510(k) notifications in patent litigation.美国食品药品监督管理局510(k)通知在专利诉讼中的使用。
Food Drug Law J. 2004;59(4):465-77.
3
Express preemption and premarket approval under the Medical Device Amendments.《医疗器械修正案》下的快速预emption和上市前批准。
Food Drug Law J. 2004;59(2):245-64.
4
To have (medical devices) or not: what's safer for patients?用（医疗设备）还是不用：什么对患者更安全？
Health Facil Manage. 1995 Jun;8(6):44, 46, 48.
5
A pivotal medical-device case.
N Engl J Med. 2008 Apr 17;358(16):1758.
6
7
A pivotal medical-device case.
N Engl J Med. 2008 Apr 17;358(16):1758. doi: 10.1056/NEJMc080148.
8
Forces reshaping the performance and contribution of the U.S. medical device industry.
Food Drug Law J. 1996;51(2):331-6.
9
Guide to preemption of state-law claims against Class III PMA medical devices.
Food Drug Law J. 2010;65(1):113-39, ii-iii.
10
The role of the patent and trademark office under 35 U.S.C. section 156.美国法典第35编第156条规定下专利商标局的职责
Food Drug Law J. 1999;54(2):205-9.
Zotero 插件